KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,837,000 | +4.0% | 15,780 | -40.0% | 0.03% | 0.0% |
| Q2 2017 | $2,727,000 | -14.9% | 26,305 | -35.5% | 0.03% | -15.4% |
| Q1 2017 | $3,203,000 | +23.2% | 40,805 | -29.6% | 0.04% | +18.2% |
| Q4 2016 | $2,599,000 | +29.0% | 57,965 | +60.8% | 0.03% | +37.5% |
| Q3 2016 | $2,014,000 | -41.2% | 36,050 | -47.4% | 0.02% | +14.3% |
| Q2 2016 | $3,426,000 | +114.1% | 68,500 | +96.6% | 0.02% | 0.0% |
| Q1 2016 | $1,600,000 | +10.3% | 34,850 | +48.0% | 0.02% | +5.0% |
| Q4 2015 | $1,451,000 | +8.1% | 23,550 | -2.3% | 0.02% | +11.1% |
| Q3 2015 | $1,342,000 | +1.7% | 24,100 | +11.3% | 0.02% | +12.5% |
| Q2 2015 | $1,320,000 | -4.4% | 21,650 | -9.6% | 0.02% | 0.0% |
| Q1 2015 | $1,381,000 | +62.9% | 23,950 | +62.9% | 0.02% | +77.8% |
| Q4 2014 | $848,000 | – | 14,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |